A new study confirms a strong link between diabetes and advanced breast cancer at diagnosis for women. Modifying breast cancer screening and detection practices...
Diabetics are at a higher risk of getting cancer and uncontrolled high blood sugar is more likely to kill them and impairs their immune...
Study shows that a specific type of diabetes drug can decrease the risk of cancer in female patients with type 2 diabetes by up to 32 percent.
Researchers have found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.
Blocking dietary sugar and its activity in tumor cells may reduce cancer risk and progression, according to researchers.
Diabetics with ovarian cancer who took the drug metformin for their diabetes had a better survival rate than patients who did not take the drug, a Mayo Clinic study shows.
A drug widely used by cancer and transplant patients also comes with a downside: it leads to diabetes in as many as 15 percent of the people who take it.
A drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study.
Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer.
The 1st study to investigate the effect of the breast cancer drug trastuzumab (Herceptin) on heart and vascular function in elderly patients has found that it increases the risk of heart problems, particularly in women with a history of heart disease, diabetes or both.
Diabetes leaders are responding to the announcement made by the FDA that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.
A new study finds that type 2 adult-onset diabetes has a surprisingly positive effect on reducing the rate of prostate cancer in men, but may double the risk of female genital and other cancers.
Studies have demonstrated that obesity and excess insulin - whether naturally produced by the body or injected in synthetic form - are associated with an increased incidence of some common cancers.
A future sensor may take away a patient's breath while simultaneously determining whether the patient has breast cancer, lung cancer, diabetes or asthma.
In a large U.S. population-based study, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome.